
About Immunoscience India Private Limited
Data last updated:
Immunoscience India Private Limited is a foreign private limited company based in Pune, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 01 July 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U73100PN2009FTC134231. Its GSTIN is 27AACCI1121K1ZV (Maharashtra).
The company has an authorised share capital of ₹10.95 Cr and a paid-up capital of ₹10.46 Cr. It is led by directors Amrut Dnyandeo Kare and Sateesh Apte.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 824/D Chintamani Apts. Bhandarkar Road Deccan, Pune, Maharashtra, India – 411004.
As per the financials filed for FY 2022, the company reported a revenue of ₹41.62 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.43 Cr (net margin 10.7%) and EBITDA of ₹5.86 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 137% over three years.
The company has about 23 employees on its provident fund (EPFO) records.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website immunoscience.in.
Company details
Contact details
Immunoscience India Private Limited's registered office is in Pune, Maharashtra. Its website is immunoscience.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address824/D Chintamani Apts. Bhandarkar Road Deccan, Pune, Maharashtra, India – 411004
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Immunoscience India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Immunoscience India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Immunoscience India Private Limited, buy the company report.
Financials of Immunoscience India Private Limited
FY 2024 filings availableImmunoscience India Private Limited reported revenue of ₹41.62 Cr (up 345% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 137% over three years, including 345% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.86 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | 10.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immunoscience India Private Limited, buy the company report.
Board of directors of Immunoscience India Private Limited
Immunoscience India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrut Dnyandeo Kare Also directs: Alpheus Pharma Private Limited, Roboscience India Private Limited | Director | 01 Jul 2009 | 17 Years 4 Months | Current |
| Sateesh Apte Also directs: Alpheus Pharma Private Limited, Roboscience India Private Limited | Director | 01 Jul 2009 | 17 Years 4 Months | Current |
Peer comparison
Immunoscience India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emergency Kits India Private Limited | ₹43.29 Cr (FY 2025) | 116.0% | Sriperumbudur, Tamil Nadu, India | |||
| Jai Surgicals Limited | ₹43 Cr (FY 2024) | -4.0% | Gurgaon, Haryana, India | |||
| Immunoscience India Private Limitedthis company | ₹41.62 Cr (FY 2022) | ₹4.43 Cr | 10.7% | 345.0% | 23 | Pune, Maharashtra, India |
| Galaxy Medicare Limited | ₹40.27 Cr (FY 2025) | 9.0% | Bhubaneswar, Odisha, India |
To see the full peer comparison of Immunoscience India Private Limited, buy the company report.
Auditor
Immunoscience India Private Limited is audited by A S CHORBELE AND COMPANY for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A S CHORBELE AND COMPANY | FY 2018 | 133580W |
Shareholding
The shareholding of Immunoscience India Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Immunoscience India Private Limited, buy the company report.
Legal cases
Immunoscience India Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Govt.Of India---Roc--- | Disposed |
To see the full case history of Immunoscience India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immunoscience India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Immunoscience India Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 23 |
| FY 2025-26 |
To see the full employee and EPFO history of Immunoscience India Private Limited, buy the company report.
GST
Immunoscience India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI1121K1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Immunoscience India Private Limited, buy the company report.
Recent activity
Immunoscience India Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Atul Ramchandra Tarade ceased to be Director on 28 Oct 2024.
Frequently asked questions
Immunoscience India is an active foreign private limited company based in Pune, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 01 July 2009 (17+ years old) and is registered under CIN U73100PN2009FTC134231.
Immunoscience India has 2 current directors:
- Amrut Dnyandeo Kare - Director
- Sateesh Apte - Director
The latest financial statements of Immunoscience India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Immunoscience India is 27AACCI1121K1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Immunoscience India is U73100PN2009FTC134231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunoscience India has 2 court cases on record: 2 filed against it.
Immunoscience India was incorporated on 01 July 2009, making it 17+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Immunoscience India by revenue are Emergency Kits India Private Limited, Jai Surgicals Limited, Galaxy Medicare Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Atul Ramchandra Tarade ceased to be Director on 28 Oct 2024. Mohit Gupta ceased to be Company Secretary on 30 Nov 2022. Amrut Dnyandeo Kare was appointed as Director on 01 Jul 2009. Immunoscience India has 4 board changes on record in total.
Immunoscience India can be reached through the website immunoscience.in. Its registered office is in Pune, Maharashtra, India.
The registered office of Immunoscience India is at 824D Chintamani Apts. Bhandarkar Road Deccan, Pune, Maharashtra, India – 411004.

